Catalyst Wire Dossier Catalyst Wire Dossier

Multi-antigen CMV-modified Vaccinia Ankara vaccine

CMV-modified vaccinia Ankara vaccine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Multi-antigen CMV-modified Vaccinia Ankara vaccine, covering 2025-10-06 to 2025-10-06. Get the full timeline:

Most recent: Clinical Trial Update: Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Treating Pediatric Patients With Positive Cytomegalovirus Undergoing Donor Stem Cell Transplant [Phase 1, Phase 2]

See pricing